As an already prevalent factor aiding in diagnosis and decision making throughout the healthcare industry, the in-vitro diagnostic (IVD) solutions market in and around Europe is expected to continue to grow at an unprecedented rate. There has been a paradigm shift from traditional diagnostics to a new generation of diagnostics that work at the gene level. This was made possible by the inclusion of advanced technologies, such as genetic testing, molecular diagnostics, polymerase chain reaction, and next-generation sequencing. Given the aforementioned factors, the in-vitro diagnostic market is anticipated to propel over the days to come.
Furthering this growth is the global evolution of the Internet of Things (IoT). It is estimated that by the year 2024, there will be over 30 billion connected devices. Amid this scenario, the software and IT community focusing on IVD technologies are stepping up to improve efficiencies, increase security, and drive revenue opportunities. The three main areas for the IVD market to capitalize on the increasingly connected world are: remote monitoring and management of IVD devices; increased efficiency and decreased downtime of devices through predictive maintenance and optimized performance; and inclusion of advanced data analytics that allow IVD devices the ability to better inform patients about their care.
At this juncture, to assist healthcare providers choose the right IVD solution provider, a distinguished panel of CEOs, CIOs, VCs, and thought leaders from the industry, along with the editorial board of MedTech Outlook, has selected the leading IVD solution providers who can help healthcare perform in-vitro diagnostics more efficiently in the days to come.
We present to you MedTech Outlook’s “Top 10 In Vitro Diagnostic Solution Companies in Europe — 2021.”